LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Profit Margin

As of the most recent data (March 2024), LSBPW shows a profit margin of -66.9%. That compares with 12.79% in the prior-year period — down 623.2% year over year. That is below the sector sector average of 13.09%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LSBPW's profit margin is now -66.9% (was 12.79%) — a 623.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) is outperforming or lagging.

The its sector sector average profit margin is about 13.09%. LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) is at -66.9%, which is lower that average. That is roughly 611.1% below the sector mean. Use the comparison chart on this page to see how LSBPW stacks up against individual peers as well.

That compares with 12.79% in the prior-year period — down 623.2% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -66.9%) with ownership activity and broader fundamentals.